Viewing Study NCT00215566

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2026-02-03 @ 4:52 PM
Study NCT ID: NCT00215566
Status: COMPLETED
Last Update Posted: 2007-05-28
First Post: 2005-09-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c
Sponsor: Dynogen Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Irritable Bowel Syndrome With Constipation View
None Irritable Bowel Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IBS View
None IBS-c View